| Caitrin Brennan Navarro, MD | |
|
81 Schoolhouse Rd, Albany, NY 12203-3850 | |
| (518) 456-1211 | |
| (518) 452-2535 |
| Full Name | Caitrin Brennan Navarro |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 81 Schoolhouse Rd, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245336213 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 217165 (New York) | Primary |
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
University of Queensland researchers have traced the origins of one of the most important steps in animal evolution - the development of nerves.
A test developed by physician-scientists at Washington University School of Medicine in St. Louis may help assess more quickly the ability of Alzheimer's drugs to affect one of the possible underlying causes of Alzheimer's disease in humans, accelerating the development of new treatments.
Researchers at the University of Massachusetts Medical School have identified a new life cycle stage in HIV infection, thanks to a novel technique they developed to take images of intact infected cells.
BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.
› Verified 1 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
University of Queensland researchers have traced the origins of one of the most important steps in animal evolution - the development of nerves.
A test developed by physician-scientists at Washington University School of Medicine in St. Louis may help assess more quickly the ability of Alzheimer's drugs to affect one of the possible underlying causes of Alzheimer's disease in humans, accelerating the development of new treatments.
Researchers at the University of Massachusetts Medical School have identified a new life cycle stage in HIV infection, thanks to a novel technique they developed to take images of intact infected cells.
BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caitrin Brennan Navarro, MD 81 Schoolhouse Rd, Albany, NY 12203-3850 Ph: (518) 456-1211 | Caitrin Brennan Navarro, MD 81 Schoolhouse Rd, Albany, NY 12203-3850 Ph: (518) 456-1211 |
News Archive
University of Queensland researchers have traced the origins of one of the most important steps in animal evolution - the development of nerves.
A test developed by physician-scientists at Washington University School of Medicine in St. Louis may help assess more quickly the ability of Alzheimer's drugs to affect one of the possible underlying causes of Alzheimer's disease in humans, accelerating the development of new treatments.
Researchers at the University of Massachusetts Medical School have identified a new life cycle stage in HIV infection, thanks to a novel technique they developed to take images of intact infected cells.
BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.
› Verified 1 days ago
Tamara Jennifer Wrzesinski, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1092 Madison Ave, Albany, NY 12208 Phone: 518-525-2445 | |
Dr. Patricia Marie Hopkins, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Albany, NY 12208 Phone: 518-262-0218 Fax: 518-262-4933 | |
Dr. Kallanna Manjunath, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 920 Lark Dr, Albany, NY 12207 Phone: 518-465-4771 Fax: 518-242-4784 | |
Lisa Benay Kamerling, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1092 Madison Ave, St. Peter's Health Care For Children, Albany, NY 12208 Phone: 518-525-2445 Fax: 518-475-7069 | |
Michael T Colon, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 319 S Manning Blvd, Suite 203, Albany, NY 12208 Phone: 518-489-3292 Fax: 518-453-6286 | |
Sarah Kathleen Klaiber Sokil, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 103 Great Oaks Blvd, Albany, NY 12203 Phone: 518-464-1392 | |
Anita Catherine Saldanha, MD PHD Pediatrics Medicare: Medicare Enrolled Practice Location: 47 New Scotland Ave, Department Of Pediatrics, Albany, NY 12208 Phone: 518-262-3095 |